Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALAI.L Regulatory News (ALAI)

  • There is currently no data for ALAI

Holding(s) in Company

18 May 2021 09:18

RNS Number : 9809Y
Aberdeen Latin American Inc Fd Ltd
18 May 2021
Ā 

ABERDEEN LATIN AMERICAN INCOME FUND LIMITED

Legal Entity Identifier (LEI): 549300DN623WEGE2MY04

Ā 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

JE00B44ZTP62

Issuer Name

ABERDEEN LATIN AMERICAN INCOME FUND LIMITED

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

1607 Capital Partners, LLC

City of registered office (if applicable)

Richmond

Country of registered office (if applicable)

United States

4. Details of the shareholder

Name

City of registered office

Country of registered office

Bank of New York Mellon

New York

United States

The Northern Trust Company

Chicago

United States

5. Date on which the threshold was crossed or reached

14-May-2021

6. Date on which Issuer notified

17-May-2021

7. Total positions of person(s) subject to the notification obligation

Ā 

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

11.090000

0.000000

11.090000

6336280

Position of previous notification (if applicable)

Ā 

Ā 

Ā 

Ā 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

JE00B44ZTP62

0

6336280

0.000000

11.090000

Sub Total 8.A

6336280

11.090000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Ā 

Ā 

Ā 

Ā 

Ā 

Sub Total 8.B1

Ā 

Ā 

Ā 

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Sub Total 8.B2

Ā 

Ā 

Ā 

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Ā 

Ā 

Ā 

Ā 

Ā 

10. In case of proxy voting

Name of the proxy holder

Ā 

The number and % of voting rights held

The date until which the voting rights will be held

Ā 

11. Additional Information

Bryan Huntley, CCO804-525-21741

12. Date of Completion

17-May-2021

13. Place Of Completion

Richmond, VA

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
HOLVVLBFFELFBBX
Date   Source Headline
27th Feb 202312:36 pmRNSNet Asset Value(s)
24th Feb 20231:33 pmRNSNet Asset Value(s)
23rd Feb 202311:41 amRNSNet Asset Value(s)
22nd Feb 202311:37 amRNSNet Asset Value(s)
21st Feb 202310:59 amRNSNet Asset Value(s)
20th Feb 20231:35 pmRNSGearing disclosure
20th Feb 202312:37 pmRNSNet Asset Value(s)
17th Feb 202312:34 pmRNSNet Asset Value(s)
16th Feb 202312:07 pmRNSNet Asset Value(s)
15th Feb 202311:31 amRNSNet Asset Value(s)
14th Feb 20234:07 pmRNSPortfolio disclosure
14th Feb 202312:28 pmRNSNet Asset Value(s)
13th Feb 20233:48 pmRNSGearing disclosure
13th Feb 202312:30 pmRNSNet Asset Value(s)
10th Feb 202312:41 pmRNSNet Asset Value(s)
9th Feb 20231:05 pmRNSNet Asset Value(s)
8th Feb 20231:24 pmRNSNet Asset Value(s)
7th Feb 20231:29 pmRNSNet Asset Value(s)
6th Feb 20234:04 pmRNSMonth End Net Asset Value(s)
6th Feb 20232:43 pmRNSGearing Disclosures
6th Feb 202312:09 pmRNSNet Asset Value(s)
3rd Feb 202312:23 pmRNSNet Asset Value(s)
2nd Feb 20231:01 pmRNSNet Asset Value(s)
31st Jan 202312:34 pmRNSNet Asset Value(s)
30th Jan 20232:10 pmRNSGearing disclosure
30th Jan 202312:31 pmRNSNet Asset Value(s)
27th Jan 202312:09 pmRNSNet Asset Value(s)
26th Jan 20234:14 pmRNSHolding(s) in Company
26th Jan 202312:00 pmRNSNet Asset Value(s)
25th Jan 202312:32 pmRNSNet Asset Value(s)
24th Jan 202312:59 pmRNSNet Asset Value(s)
23rd Jan 20234:23 pmRNSGearing disclosure
23rd Jan 202312:35 pmRNSNet Asset Value(s)
20th Jan 202312:48 pmRNSNet Asset Value(s)
19th Jan 202312:43 pmRNSNet Asset Value(s)
18th Jan 20235:10 pmRNSNet Asset Value(s)
18th Jan 202310:53 amRNSPortfolio disclosure
17th Jan 202312:19 pmRNSNet Asset Value(s)
16th Jan 20232:12 pmRNSGearing disclosure
16th Jan 20231:05 pmRNSNet Asset Value(s)
13th Jan 20231:08 pmRNSNet Asset Value(s)
12th Jan 202312:05 pmRNSNet Asset Value(s)
11th Jan 202311:10 amRNSNet Asset Value(s)
10th Jan 202312:02 pmRNSNet Asset Value(s)
9th Jan 20235:18 pmRNSGearing disclosure
9th Jan 202312:13 pmRNSNet Asset Value(s)
6th Jan 20233:03 pmRNSMonth End Net Asset Value(s)
6th Jan 202312:52 pmRNSNet Asset Value(s)
5th Jan 202312:11 pmRNSNet Asset Value(s)
4th Jan 202312:22 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.